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patial patterning of chemical and physical properties of
surfaces has been used to control the behavior of cultured
cells for decades.
1 7 Most of these early methods were based on
patterningextracellularmatrixproteins,eitherdirectlyorbymodu-
latingtheirdepositionbythecellsthemselves.Subsequently,more
reﬁned technologies began to focus more on speciﬁc ligand
display. Such synthetically designed platforms have already pro-
vided substantial insight into how cellular functions such as
adhesion,
8 migration,
9,10 proliferation,
11 diﬀerentiation,
12 as well
as speciﬁc receptor activation and the role of spatial organiza-
tion
13,14 are regulatedon themolecularlevel. For example, micro-
andnanopatternedarraysofadhesionmoleculeshavebeenusedto
investigate how spatial diﬀerences of only a few nanometers can
inﬂuence cell fate and response.
6 These experiments revealed that
ﬁbroblasts can apparently sense even nanoscale gradients of
adhesionmolecules,andunderscoretheprecisionwithwhichcells
control and react tothespatialorganization of molecules.
15While
useful inmanycases, immobile patterningintrinsicallydefeats any
cellular process that naturally involves movement of the ligands,
such as is particularly common among juxtacrine signaling in
cell cell junctions where both receptor and ligand reside in the
ﬂuid cell membranes.
One material platform technology that has proven particu-
larly useful to address the more ﬂuid nature of intercellular
interactions is the supported membrane.
16 Lipid bilayers can be
assembled on solid surfaces in such a way that they form a single,
continuous, membrane that coats the underlying solid sub-
strate but maintains a high degree of lateral mobility in the
membrane.
16 18 Lipid mobilities in supported membranes are
typically 3 4 μm
2/s, which, while several times slower than that
offreebilayermembranes(e.g.,ingiantunilamellarvesicles
19),is
still faster than lipid mobility (∼1 μm
2/s) in the crowded
membranes of living cells.
20 Thus supported membranes en-
able ligand display along with freedom to move and reorganize
naturally. Supported membranes have found productive applica-
tions instudies oftheTcellimmunologicalsynapse,
21 26neuro-
nal interactions,
27,28 and the triggering of EphA2 receptor
tyrosine kinase in breast epithelial cancer cells.
29,30 Supported
membranes provide the added advantage that materials such as
metals can be patterned onto the underlying substrate so as to
impose ﬁxed barriers or obstacles to mobility of molecules in the
supported membrane.
21,23,24,31 Such patterned supported mem-
branes intrinsically embody a combination of mobile and im-
mobile characteristics, which can be used to glean insights into
the function of living cells and especially the role of spatial
organization and assembly in cellular processes.
32,33
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ABSTRACT: We present a supported membrane platform
consisting of a ﬂuid lipid bilayer membrane embedded with a
ﬁxed array of gold nanoparticles. The system is realized by
preformingahexagonalarrayofgoldnanoparticles(∼5 7nm)
withcontrolled spacing (∼50 150 nm) ﬁxed toasilica orglass
substrate by block copolymer lithography. Subsequently, a
supported membrane is assembled over the intervening bare
substrate. Proteins or other ligands can be associated with the ﬂuid lipid component, the ﬁxed nanoparticle component, or both,
providingahybridinterfaceconsistingofmobileandimmobilecomponentswithcontrolledgeometry.Wetestdiﬀerentbiochemical
coupling strategies to bind individual proteins to the particles surrounded by a ﬂuid lipid membrane. The coupling eﬃciency to
nanoparticles and the inﬂuence of nanoparticle arrays on the surrounding membrane integrity are characterized by ﬂuorescence
imaging,correlationspectroscopy,andsuper-resolutionﬂuorescencemicroscopy.Finally,thefunctionalityofthissystemforlivecell
experiments is tested using the ephrin-A1 EphA2 juxtacrine signaling interaction in human breast epithelial cells.
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In this report, we describe the fabrication and characterization
of a hybrid nanoparticle and supported membrane conﬁguration
consisting of an immobile array of nanoparticles embedded
within a ﬂuid supported membrane (Figure 1A D). Nanopar-
ticle arrays are formed by block copolymer micelle nanolitho-
graphy (BCML),
34 in which nucleation sites for nanoparticle
growth are ﬁrst ordered by self-assembly of block copolymer
micelle arrays. The organic component is subsequently plasma
etched,leavinganorderedarrayofnanoparticlesonthesubstrate
whose spacing is dictated by the original polymer molecular
weight. Key features of this system are the extraordinarily small
size of the gold nanoparticles (∼5 7 nm), which enables
functionalization with individual protein molecules, and the con-
trollable spacing between particles in the array in the important
range of 50 150 nm, all of which are under direct synthetic
control. Importantly, the BCML method of fabricating nanopar-
ticle arrays is a self-assembly process and does not require
complex patterning methods such as electron beam lithography
or nanoimprint lithography.
34 Supported membranes can be
assembled on these surfaces and orthogonal chemistries can be
employedtofunctionalizetheparticlesthemselves.Fluorescence
correlation spectroscopy and super-resolution microscopy
are used here to examine membrane integrity and ligand coupl-
ing eﬃciency to the nanoparticles. Finally, application of this
technology to the ephrin-A1 EphA2 signaling system in breast
epithelial cells is examined as a test of its utility in a live cell
format.
Nanoparticle Fabrication and Supported Lipid Bilayers.
Arraysofgoldnanoparticleswerepreparedusingdiblockcopoly-
mersofpolystyrene(PS)-block-poly(2-vinylpyridine)whichwere
dissolved in toluene. The polymer chains microphase separate
into a micelle morphology with the polystyrene-block forming
the outer shell and the vinylpyridine-chain forming the micellar
core that can be loaded with a stoichiometric amount of a gold
metal precursor. The micelles are transferred to the surface of a
glass substrate by dip-coating with constant speed.
35 The sample
is then treated with air plasma to remove the polymer matrix,
leaving behind an array of gold nanoparticles (Figure 1E). The
separation distance between the individual particles is adjustable
by the molecular weight of the block copolymer and the dip-
coating conditions.
35
Supported lipid bilayers are formed by vesicle fusion from a
solution of single unilamellar vesicles (SUVs).
18,36 For the
experiments described here, the particle diameter was set to
7 nm, which is comparable to the thickness of the supported
membrane.
37 39 Furthermore, Roiter et al. found that nano-
particles in a size range between 1.2 and 22 nm are closely
surrounded by a lipid membrane instead of being covered by the
bilayer.
39,40 SUVs prepared by both extrusion and probe sonica-
tion methods were used with no observable diﬀerence in the
results. Representative ﬂuorescence images, including ﬁeld-stop
aperture ﬂuorescence recovery after photobleaching (FRAP),
18,41
of a supported membrane coated substrate with embedded
nanoparticles is illustrated in Figure 2. The dipping edge is visible
as a dark line dividing the epiﬂuorescent image (Figure 2A, white
arrow).Onlytheareabelowthedippingedgeiscoveredwithgold
particles (105 nm spacing in this example); the area above
corresponds to the bare glass substrate and serves as an internal
reference. FRAP performed with a bleach spot straddling the
dipping edge indicates comparable membrane continuity and
mobility on both sides.
Theinﬂuenceofthenanoparticledensityonthelipiddiﬀusion
was investigated in greater quantitative detail using ﬂuorescence
correlation spectroscopy (FCS).
42,43 Samples with particle spa-
cings ranging from 58 to 151 nm were examined while keeping
theparticlesizeconstant.Twodiﬀerent membrane systems were
investigated: 0.008% TexadRed-DHPE doped bilayer of DOPC
andHis12-mGFPanchoredtoa98.0%DOPCmembranedoped
with 2.00% Ni-DOGS (a DOGS lipid with a nickel-chelating,
nitrilotriacetic acid (NTA) headgroup) following a previous
protocol.
44 For the TexasRed lipid probe, measured diﬀusion
coeﬃcients were 2 μm
2/s for all particle densities with no signi-
ﬁcantdiﬀerencebetweentheparticleandtheglassside(Figure2G).
The His12-mGFP exhibited diﬀusion coeﬃcients ranging between
Figure 1. Schematic overview ofthe fabrication steps:(A)Gold nanoparticlearraysare formedbyblockcopolymermicelle nanolithography(BCML).
(B) Supported lipid bilayer formation by vesicle fusion. (C) Selective labeling of the gold nanoparticles. (D) Live-cell experiments with speciﬁc
ligands bound to the nanoparticles and the lipid bilayer, respectively. (E) SEM micrographs of gold nanoparticle arrays from ﬁve diﬀerent samples
with individual particle spacing varying between 58 and 151 nm. The small particle size of ∼5 7 nm matches the height of supported bilayer.
Scale bar: 200 nm.4914 dx.doi.org/10.1021/nl202847t |Nano Lett. 2011, 11, 4912–4918
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1and2μm
2/s(Figure2H)withonlyasmalltrendtofasterdiﬀusion
with larger particle spacing. For a substrate with such a high density
of features, we consider the possibility of signiﬁcant edge eﬀects to
be a real risk.
45 Signiﬁcantly, no measurable eﬀect from area exclu-
sion due to the nanoparticles was observed, indicating that the
mobile supported membrane persists quite close to the gold nano-
particle itself, without a substantial boundary area.
NanoparticleFunctionalizationStrategiesandSingleMo-
leculeFluorescenceMicroscopy.Fourstrategiesweretestedto
bind fluorescent proteins and ligands to the gold nanoparticles
embedded in a lipid bilayer (Figure 3A). Three of the linker
systems tested following a two-step approach: polyhistidine 
Ni
2+ NTA coordination chemistry,
46 N-hydroxysuccinimide
(NHS) ester covalent coupling,
47 and biotin streptavidin affi-
nity binding. For the two step approaches, thiol and disulfide
linker molecules were first covalently bound to individual gold
particles. In a second step, fluorescently labeled proteins were
then bound to the specific linker. Double-stranded DNA with a
thiolgroupatone50 endanda6-carboxyfluorescein(FAM)group
at the 50 end of the complementary strand was used to functio-
nalizethenanoparticlesinasinglestep.Forallmethods,successful
couplingwascharacterizedbyfluorescencemicroscopy(Figure3B).
Fluorescence was observed only on the nanoparticle; negligible
fluorescence was observed off the nanoparticle arrays or in control
experiments without linker molecules.
Comparing all four methods, His-tag-Ni
2+/NTA coupling
proved most advantageous as it allows site-speciﬁc protein
immobilization with high binding aﬃnity and control over the
binding orientation. However, the method suﬀers from unbind-
ing over time due to instability of the Ni(II)-coordinating
complex.
44 Alternatively, N-hydroxysuccinimide (NHS) esters
can bind to primary amines from proteins forming a covalent
amide bond. However, protein labeling is not site-selective,
which could jeopardize the protein functionality. In addition,
NHS suﬀers from unwanted side-reactions with water molecules
in aqueous solution. Biotin streptavidin is a popular strategy of
creatinghighaﬃnitylinkages,butthisisnotsite-selectiveandthe
multivalency of streptavidin as well as its intrinsic tendency to
oligomerizecreatesanavenueforaggregation.Indeed,weobserve
largeﬂuorescentaggregatesforbiotincoupling(Figure3B).DNA
oﬀersmanybeneﬁtsforanchoringproteins,includingespeciallyits
potential for massive orthogonality. In addition the length and
ﬂexibilityoftheDNAmoleculescanbetunedasneeded.Theseare
not examined in detail here.
Figure2. Probingmembraneﬂuidityinthepresenceofgoldnanoparticles:(A)Fluorescencerecoveryafterphotobleaching(FRAP)onabilayerof1,2-
dioleoylphosphotidylcholine (DOPC) doped with 0.5% TexasRed-DHPE (1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine, triethyl-ammo-
niumsalt):Thedippingedge(whitearrow)representstheborderlinetowheretheglasssubstrateiscoveredwithnanoparticles.Priortophotobleaching
ﬂuorescence is detectable on both sides of the dipping edge (top, glass side; bottom, nanoparticle side). (B) A bleached central spot is visible after
illuminatingthesamplefor1minwithintenselight.(C)After2min,ﬂuorescencehasrecoveredonbothsidesofthedippingedgewiththesamerate.(D)
Line scan of the ﬂuorescence intensity before and after 2 min displays the recovery of ﬂuorescence. (E) RICM image of the dipping edge: FCS
measurementswereperformedontheglassandthenanoparticlesidetocomparethebilayerdiﬀusioncoeﬃcientsasafunctionoftheparticledensity.(F)
Fluorescence correlation curves measure on the glass (red) and the nanoparticle side (green). (G, H) Diﬀusion coeﬃcient as a function of the
nanoparticlespacingmeasuredbyFCS:(G)DOPCbilayerdopedwith0.008%TexasRed;(H)His12-mGFPanchoredtotheDOPCbilayerdopedwith
2% Ni-DOGS lipids.4915 dx.doi.org/10.1021/nl202847t |Nano Lett. 2011, 11, 4912–4918
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Protein coupling to individual nanoparticles was analyzed by
photoactivated localization microscopy (PALM).
48,49 For this
study, ephrinA1-mEos-His10 fusion proteins were attached to
the gold nanoparticles using Ni(II)-coordinating NTA coupling
as described above. The photoactivatable ﬂuorescent protein
(PAFP) mEos2 is suitable for PALM experiments because it
irreversibly isomerizes from a green to a red ﬂuorescent state
upon irradiation with UV light and to date has one of the highest
photon yields and highest contrast between bright and dark
ﬂuorescent states of all PAFPs.
50 Individual mEos2 molecules
Figure3. (A)Overviewonfunctionalizationstrategiesforgoldnanoparticlesinthepresenceofalipidbilayer:(1)CouplingofHis-taggedmoleculesto
goldnanoparticlesviaNi(II)-coordinatingNTA-thiollinkermolecules.(2)N-Hydroxysuccinimide(NHS)couplingofproteins:Thesuccinimidylesters
group reacts with primary amines from proteins by forming a stable amide bond (ﬁgure inset). Since NHS is a good leaving group, hydrolysis of the
activated ester occurs as a side reaction in water. (3) Biotin streptavidin aﬃnity binding: Biotin thiol linker molecules are bound to the particles in
buﬀersolution.Biotin-functionalizedproteinsareattachedviabiotin streptavidincoupling.Streptavidindisplaysfourbindingsitestobindbiotinylated
proteins.(4)Labelingwiththiolated-DNAwithathiolgroupatone50 endanda6-carboxyﬂuorescein(FAM)groupatthe50 endofthecomplementary
strand. (B) Epiﬂuorescence images of immobilized ﬂuorescent labeled proteins bound to gold nanoparticles. Scale bars: 5 μm.4916 dx.doi.org/10.1021/nl202847t |Nano Lett. 2011, 11, 4912–4918
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were activated using a 405 nm laser pulse for 1 s in 20 s
increments while continuously imaging the sample until theﬁeld
of view showed complete depletion (Figure 4D). Small defects
were observed where the mEOS could not be bleached over the
course of the data acquisition (Figure 4C,D). These spots are
likelycausedbycontaminationsanddefectsontheglasssubstrate
that lead to particle agglomerations or holes in the bilayer itself.
PALM images were constructed according to Gould et al.
51 The
nearest neighbor distance of ﬂuorescent molecules from the
PALM rendered image was compared to the particle spacing
from a reference SEM micrograph by calculating the radial dis-
tribution functions g(r)
52 (Figure 4G). A molecule spacing of
approximately 100 nm was calculated for the full PALM image,
which is in good agreement with the data calculated from SEM
imaging of the nanoparticles themselves (∼110 nm). The coupl-
ing yield of mEos2 molecules to individual gold particles was
foundto be24%by comparingthe number of goldnanoparticles
measured by SEM with the number of ﬂuorophores localized
withPALM.Ithastobenotedthattheoverallnumberofdetected
particles depends on several experimental parameters such as the
labeling yield of the NTA linker to the gold particles, the labeling
yield of the mEOS2 to the linker, the absolute number or active/
inactive mEOS2 molecules, and the eﬃciency of the PALM
readout.Noparticleswerelostduetothefunctionalizationprocess
as veriﬁed by SEM (Supporting Information).
LiveCellExperiments.Live cell experiments were performed
with MDA-MB-231 cells, a highly invasive human breast epithe-
lial cancer cell line.
53 This particular cell line is known for
overexpressing the EphA2 receptor tyrosine kinase that interacts
with its biological ligand, ephrin-A1, in juxtracrine fashion and
has been used in previous studies by our group.
29,30 The cells do
not exhibit any nonspecific interaction with the control sub-
strates consisting of unfunctionalized nanoparticles or of nano-
particlesfunctionalizedwithNTA-linkermoleculesonly(Figure5A).
Incontrast,prolificadhesionwasobservedonthenanoparticlesideof
the substrate (Figure 5B). In a contrasting experiment, cells were
exposedtoasubstrateinwhichthemembranewasdopedinanRGD
(arginine glycine asparatic acid) motif bound to a mobile lipid.
RGD is a peptide sequence that is found in extracellular matrix
proteins and known to promote integrin-mediated cell adhesion.
54
Figure 4. PALMimagingofephrin-mEos-His10anchoredto goldnanoparticles: (A)TIRFimage using488nmillumination(green ﬂuorescentstate).
(B) TIRF image of the same area as in (A) using 561 nm illumination with the ﬁeld diaphragm fully open after intense activation pulse using 405 nm
TIRF illumination (red ﬂuorescent state). After activation with the 405 pulse the TIRF image using 561 nm illumination shows that only molecules
withintheﬁelddiaphragmwereactivatedwhilethoseontheoutsidearenotactivatedandthereforedarkunder561nmillumination.(C)PALMimageof
the ﬂuorescent molecules. (D) Atlaser powers of20 30 mW, 561 nm, and 0.1 1 mW, 405 nm, bothmeasured atthe sample, the ﬁeld ofview showed
completedepletionofﬂuorescenceafterapproximately30minusing100msexposuretimesandstreamacquisition.Defectsfromthenanoparticlearray
are visible in both the PALM and 561 TIRF images (red circles). (E) Schematic of the laser illumination sequence. Individual mEos2 molecules were
activatedusinga405nmlaserpulsefor1sin20sincrementswhilecontinuouslyimagingthesamplewitha561nmlaserinTIRFmode.(F,right)Close-
upofindividualmoleculesdetectedbyPALMand(F,left)referenceSEMimageofthesamesample.Scalebaris200nminbothcases.(G)Comparison
of the radial distribution function from the full PALM image (black) and the reference SEM image (red).4917 dx.doi.org/10.1021/nl202847t |Nano Lett. 2011, 11, 4912–4918
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In this experiment, both the bilayer and the nanoparticles were
functionalizedwithmoleculesthatpromotecelladhesionandthecells
were found all over the substrate (Figure 5C).
These results are the ﬁrst example of an advanced platform of
ﬁxed gold nanoparticle arrays and supported lipid bilayers for
biological studies. This new strategy that combines ﬁxed nano-
patterningwiththemobilityofﬂuidsupportedlipidbilayersisan
important improvement over previous methods that use strictly
mobile or strictly static protein patterning and oﬀers great
potential for future studies of living cells.
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